This brief survey of breast cancer symptoms was developed and administered to women enrolled in the Breast Cancer Prevention Trial (BCPT) conducted by the National Surgical Adjuvant Breast and Bowel Project.
BCPT Eight Symptom Scale (BESS)
NUMBER OF ITEMS:
Breast cancer patients 18 years and older
Past four weeks
5 point Likert-type scale
Paper and electronic
Self-administration and interview when applicable
TIME FOR COMPLETION:
Manual scoring template. Subscale scores possible.
Available translations of the BESS can be obtained when licensing the measure. Users are not permitted to translate the BESS without prior permission from FACIT.org. Permission may also be contingent upon timeline expectations and availability of FACIT staff. Translations must undergo a rigorous methodology under the guidance of FACIT.org which includes multiple translators and cognitive interviews with patients. For commercial use, FACITtrans is the approved translation vendor of the BESS.
Please contact us for more information.
Licensing fees are assessed on a per trial/per measure basis for commercial use. There is no fee for use of the English version, but a license should be obtained.
Non-commercial use is assessed on a case-by-case basis. Licensing fees are typically not applied to investigator-initiated research, students, or clinical use.
To license an available version of this measure for commercial or non-commercial use, please complete our registration form. All of the information provided in the form will be kept strictly confidential. For questions, please contact us.
Cella D, Land SR, Chang CH, Day R, Costantino JP, Wolmark N, Ganz PA. Symptom measurement in the Breast Cancer Prevention Trial (BCPT) (P-1): psychometric properties of a new measure of symptoms for midlife women. Breast Cancer Res Treat. 2008 Jun;109(3):515-26. doi: 10.1007/s10549-007-9682-9. Epub 2007 Sep 13. PMID: 17851765.
Terhorst, L., Blair-Belansky, H., Moore, P. J., & Bender, C. (2011). Evaluation of the psychometric properties of the BCPT Symptom Checklist with a sample of breast cancer patients before and after adjuvant therapy. Psycho-oncology, 20(9), 961–968.